NOVO NORDISK A S (NVO) is held by 5 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds adding and 3 funds trimming or exiting versus the previous quarter. 1 member of Congress reported 1 purchase vs 2 sales. Latest close $39.43 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.
Markel Group · Causeway Capital Management · Maverick Capital — 5 tracked funds hold NVO. See all holders.
1 member of Congress reported buying (1 purchase vs 2 sales). Latest buy: Aug 26, 2026. Politician trading
ALLSTATE CORP (ALL) · CARRIER GLOBAL Corp (CARR) · NORFOLK SOUTHERN CORP (NSC) · TORONTO DOMINION BANK (TD) · COMFORT SYSTEMS USA INC (FIX) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Markel Group | 1.05% | 2,869,774 | HELD Q3 filed Oct 30 |
| Causeway Capital Management | 0.87% | 1,677,615 | ADDED (+42.9%) Q3 filed Nov 13 |
| Maverick Capital | 0.70% | 1,653,872 | TRIMMED (-20.5%) Q3 filed Nov 16 |
| Dodge & Cox Funds | 0.51% | 20,397,110 | ADDED (+5.5%) Q3 filed Nov 13 |
| Saturna Capital | 0.07% | 116,291 | TRIMMED (-93.5%) Q3 filed Nov 16 |
| Giverny Capital | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -16.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 1,361 of 8,857 filers |
| Long-only filers among them | 1,348 |
| Change vs 2026 Q1 | +88 net · 1,166 entered · 1,078 exited |
| Shares reported, all filers | 325,845,081 |
| Reported value, all filers | $19.2B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations (SIC 2834) |
| Revenue · FY2025 | 309.1B DKK |
| Net income · FY2025 | 102.4B DKK |
| Total assets · FY2025 | 542.9B DKK |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026.
| Shares short · Oct 15, 2026 | 37,436,108 |
| Days to cover | 3.11 |
Shares short at recent settlements — Jul 31, 2026: 29.4M · Aug 14, 2026: 33.8M · Aug 31, 2026: 31.6M · Sep 15, 2026: 26.3M · Sep 30, 2026: 31.6M · Oct 15, 2026: 37.4M.
Source: FINRA Equity Short Interest (biweekly settlement data).
| Shares failed to deliver · Oct 14, 2026 | 1,902 |
| Fails as a share of short interest · Oct 15, 2026 | <0.1% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 7K · Sep 30, 2026: 0 · Oct 14, 2026: 2K.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns.
Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| May 30, 2025 | Novo Nordisk A/S | 10% Stockholder | 921,897 | $2.0M | May 30, 2025 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Apr 23, 2025 | BlackRock, Inc. | SC 13G/A | 177,801,601 | 5.2% | Mar 31, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
1 member of Congress reported buying (1 purchase vs 2 sales). Bought by Republicans. Latest buy: Aug 26, 2026.
Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.
Recent activity by member
| Member | Chamber | Party | Buys | Sells | Latest | Amount range |
|---|---|---|---|---|---|---|
| Hern, Kevin | House | R | 0 | 2 | Sep 10, 2026 | $1,001 - $15,000 |
| Franklin, Scott | House | R | 1 | 0 | Aug 26, 2026 | $1,001 - $15,000 |
Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.
Industry: Pharmaceutical Preparations (SIC 2834). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Politicians
· Bought by Members — Last 6 months: bought by a member of the U.S. Congress
Key figures
· Bought by Members — Members buying: 1 · Buy txns: 1 · Sell txns: 2 · Latest buy: Aug 26, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Politician BEST — appeared in 1 of the last 20 quarterly lists; latest 2025 Q3, ranked #6 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 6 | 66.7% | +5.0% | +4.5% | +0.4% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold NVO — ranked by lift, the co-holding pattern described in Methodology: ALLSTATE CORP (ALL) · CARRIER GLOBAL Corp (CARR) · NORFOLK SOUTHERN CORP (NSC) · TORONTO DOMINION BANK (TD) · COMFORT SYSTEMS USA INC (FIX) · MICROCHIP TECHNOLOGY INC (MCHP) · Sanofi (SNY) · BARRICK MINING CORP (B).
No Form 8-K filings for this ticker in the index (Jan 2023 – present).
ALLSTATE CORP (ALL) · Track Record: how the signals scored · Practice timing on NVO
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.